Suppr超能文献

检测特发性垂体功能减退伴生长激素缺乏症患者成年人群中的遗传性垂体功能减退症。

Detection of genetic hypopituitarism in an adult population of idiopathic pituitary insufficiency patients with growth hormone deficiency.

机构信息

Department of Endocrinology, Sahlgrenska Academy, University of Gothenburg, Gröna Stråket 8, 41345, Gothenburg, Sweden.

出版信息

Pituitary. 2011 Sep;14(3):208-16. doi: 10.1007/s11102-010-0278-8.

Abstract

Idiopathic pituitary insufficiency (IPI) is diagnosed in 10% of all hypopituitary patients. There are several known and unknown aetiologies within the IPI group. The aim of this study was to investigate an adult IPI population for genetic cause according a screening schedule. From files of 373 GH deficient (GHD) patients on GH replacement 50 cases with IPI were identified. Of the 39 patients that approved to the study, 25 patients were selected for genetic investigation according to phenotype and 14 patients were not further tested, as sporadic isolated GHD (n = 9) and GHD with diabetes insipidus (n = 5) have low probability for a known genetic cause. Genotyping of all coding exons of HESX1, LHX4, PROP1, POU1F1 and GH1 genes were performed according to a diagnostic algorithm based on clinical, hormonal and neuroradiological phenotype. Among the 25 patients, an overall rate of 8% of mutations was found, and a 50% rate in familial cases. Among two sibling pairs, one pair that presented with complete anterior pituitary insufficiency, had a compound heterozygous PROP1 gene mutation (codons 117 and 120: exon 3 p Phe 117 Ile (c349 T>A) and p Arg 120 Cys (c358 C>T)) with a phenotype of very late onset ACTH-insufficiency. In the other sibling pair and in the sporadic cases no mutation was identified. This study suggests that currently known genetic causes are rare in sporadic adult IPI patients, and that systematic genetic screening is not needed in adult-onset sporadic cases of IPI. Conversely, familial cases are highly suspect for genetic causes.

摘要

特发性垂体功能减退症(IPI)在所有垂体功能减退症患者中占 10%。在 IPI 组中有几种已知和未知的病因。本研究旨在根据筛查方案调查成人 IPI 人群的遗传病因。从接受 GH 替代治疗的 373 例生长激素缺乏症(GHD)患者的档案中,确定了 50 例 IPI 患者。在同意参加研究的 39 名患者中,根据表型选择了 25 名患者进行遗传调查,另外 14 名患者未进一步检测,因为散发性孤立性 GHD(n=9)和伴有尿崩症的 GHD(n=5)具有低概率的已知遗传病因。根据基于临床、激素和神经影像学表型的诊断算法,对 HESX1、LHX4、PROP1、POU1F1 和 GH1 基因的所有编码外显子进行了基因分型。在 25 名患者中,发现突变总体率为 8%,家族病例率为 50%。在两个同胞对中,一对表现为完全性垂体前叶功能减退症的患者,存在 PROP1 基因复合杂合突变(外显子 3 上的密码子 117 和 120:p Phe 117 Ile(c349 T>A)和 p Arg 120 Cys(c358 C>T)),伴有非常晚发性 ACTH 功能减退症的表型。在另一对同胞和散发性病例中,未发现突变。本研究表明,目前已知的遗传病因在散发性成人 IPI 患者中较为罕见,且在成人起病的散发性 IPI 病例中,无需进行系统的遗传筛查。相反,家族病例高度怀疑存在遗传病因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验